SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
October 2, 1997
Mallinckrodt Inc.
(Exact name of registrant as specified in its charter)
New York 1-483 36-1263901
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
7733 Forsyth Boulevard, St. Louis, MO 63105-1820
(Address of principal executive offices) (ZIP Code)
Registrant's telephone number, (314) 854-5200
including area code
<PAGE>
Item 5. A press release was issued October 2, 1997. The relevant
portion of the text of that release was as follows:
(*) Indicates registered trademark.
APPEALS COURT STAYS INJUNCTION; MALLINCKRODT CAN CONTINUE TO SELL
WarmTouch(*) BLANKETS IN U. S.
ST. LOUIS, Mo., October 2, 1997 - Mallinckrodt Inc. (NYSE:MKG) can
continue to sell its WarmTouch(*) patient warming blankets in the
United States under a temporary stay of injunction issued yesterday
by the federal court of appeals in Washington, D. C. Augustine,
another manufacturer of patient warming systems, recently won a
patent infringement decision against Mallinckrodt. This decision is
being appealed by Mallinckrodt.
The temporary stay is in effect until Augustine Medical submits
its response - which is due October 7 - and the court determines
whether the stay should be extended until Mallinckrodt's appeal is
decided.
"We are pleased that the court has taken this action," said
Thomas R. Trotter, president of Mallinckrodt's Critical Care
Division. "This will allow us to continue serving our hospital
customers and to ensure that service to patients will not be
disrupted."
WarmTouch(*) blankets connect to blowers that fill the blankets
with warm air. This creates a warming system that helps control
patient body temperatures. Medical research has demonstrated patient
benefits from such warming, including improved post-surgical recovery
time and reduced incidences and severity of wound infection after
surgery.
Mallinckrodt Inc. serves healthcare and specialty chemicals
markets worldwide. The company has four major businesses -
pharmaceuticals, diagnostic imaging, respiratory care and specialty
chemicals. The St. Louis, Missouri-based company, with fiscal 1997
net adjusted sales of $1.9 billion, operates in more than 100
countries. The Mallinckrodt web site address is
(www.mallinckrodt.com).
# # #
Mallinckrodt Inc.
Roger A. Keller
Vice President, Secretary
and General Counsel
DATE: October 6, 1997
